Outpatient and Emergency Department Visits€¦ · 15-05-2020 · • Public health laboratories – decreased from 13.1% during week 18 to 11.8% during week 19; • Clinical laboratories

Nationally, levels of influenza-like illness (ILI) and COVID-19-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2, the virus that causes COVID-19, continue to decline. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are counted.

Key Updates for Week 19, ending May 9, 2020

The national percentage of respiratory specimens testing positive for SARS-CoV-2 at public health, clinical and commercial laboratories decreased from week 18 to week 19. Percentages by type of laboratory:

• Public health laboratories – decreased from 13.1% during week 18 to 11.8% during week 19;

• Clinical laboratories – decreased from 8.4% during week 18 to 6.9% during week 19;

• Commercial laboratories – decreased from 13.0% during week 18 to 10.2% during week 19.

Two indicators from existing surveillance systems are being used to track outpatient or emergency department (ED) visits for illness with symptoms compatible with COVID-19.

• Nationally, the percentages of visits for ILI and CLI decreased compared to last week. Levels of ILI are now below baseline nationally for the third week and in all 10 surveillance regions.

Recent changes in health care seeking behavior, including increasing use of telemedicine, recommendations to limit emergency department (ED) visits to severe illnesses, and increased practice of social distancing, are likely affecting data reported from both networks, making it difficult to draw further conclusions at this time. Tracking these systems moving forward will give additional insight into illness related to COVID-19.

Cumulative COVID-19-associated hospitalization rates since March 1, 2020, are updated weekly. The overall cumulative hospitalization rate is 60.5 per 100,000, with the highest rates in people aged 65 years and older (192.4 per 100,000) and 50-64 years (94.4 per 100,000).

Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 17.8% during week 18 to 12.8% during week 19 but remained above baseline. This is the third week of a declining percentage of deaths due to PIC, but this percentage may change as more death certificates are processed, particularly for recent weeks.

Virus

Outpatient and Emergency Department Visits

Severe Disease

Public Health, Commercial and Clinical Laboratories

Outpatient Influenza-Like Illness Network (ILINet) and National Syndromic Surveillance Program (NSSP)

Hospitalizations Mortality

All data are preliminary and may change as more reports are received. A description of the surveillance systems summarized in COVIDView, including methodology and detailed descriptions of each data component, is available on the surveillance methods page.

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html

2 COVIDView Week 19, ending May 9, 2020

Key Points

o Nationally, the percentages of laboratory specimens testing positive for SARS-CoV-2 decreased compared to last week.

o While the number of specimens from children <18 years of age tested is low (<5% of all specimens tested in public health and commercial laboratories), the percentage of these testing positive for SARS-CoV-2 in this age group has either trended upward or remained relatively stable in recent weeks. Other age groups have seen declines in percent positivity during the same time period.

o Nationally, visits to outpatient providers and emergency departments (EDs) for illnesses with symptoms consistent with COVID-19 continued to decline. Outpatient ILI visits are below baseline nationally and in all regions of the country.

o The decrease in the percentage of people presenting for care with ILI and CLI may be due to a decline in COVID-19 illness, which could be in part a result of widespread adoption of social distancing in addition to changes in healthcare seeking behavior.

o There has been very little influenza virus activity in recent weeks.

o The overall cumulative COVID-19 associated hospitalization rate is 60.5 per 100,000, with the highest rates in people 65 years of age and older (192.4 per 100,000) and 50-64 years (94.4 per 100,000). Hospitalization rates are cumulative and will increase as the COVID-19 pandemic continues.

o Hospitalization rates for COVID-19 in adults (18-64 years) are already higher than hospitalization rates for influenza at comparable time points* during the past 5 influenza seasons.

o For people 65 years and older, current COVID-19 hospitalization rates are within ranges of influenza hospitalization rates observed at comparable time points* during recent influenza seasons.

o For children (0-17 years), COVID-19 hospitalization rates are much lower than influenza hospitalization rates at comparable time points* during recent influenza seasons.

o Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 17.8% during week 18 to 12.8% during week 19, but remained above baseline. This is the third week during which a declining percentage of deaths due to PIC has been seen, but the percentage remains high compared with any influenza season. The percentage may change as additional death certificates for deaths during recent weeks are processed.

*Number of weeks since 10% of specimens tested positive for SARS-CoV-2 and influenza, respectively.


National and Regional Summary of Select Surveillance Components

Laboratory Data* Outpatient/ED Data Mortality

% SARS-CoV-2

Positive

Trend

ILINet NSSP

% PIC

Relative to

Epidemic Threshold

Trend % ILI

Relative to

Baseline Trend

% CLI

Trend

National 10.2 Declining (5 weeks)

1.2 Below Declining (7 weeks)

2.8 Declining (5 weeks)

12.8 Above Declining (3 weeks)

Region 1





Region 2





Region 3





Region 4





Region 5





Region 6





Region 7


0.6 Below Declining (1 week)



Region 8

7.2 Increasing (1 week)



5.0 Below Declining (2 week)

Region 9


1.2 Below No

change 2.5

Declining (7 weeks)


Region 10




Insufficient Data for Week 19

* Public health, clinical and commercial laboratory data combined.


U.S. Virologic Surveillance The number of specimens tested for SARS-CoV-2 and reported to CDC by public health laboratories and a subset of clinical and commercial laboratories in the United States are summarized below. At this point in the outbreak, all laboratories are performing primary diagnostic functions; therefore, the percentage of specimens testing positive across laboratory types can be used to monitor trends in COVID-19 activity. As the outbreak progresses, it is possible that different types of laboratories will take on different roles, and the data interpretation may need to change. The lower percentage of specimens testing positive in clinical laboratories compared to public health and commercial laboratories may be influenced by COVID-19 activity in areas with reporting laboratories and by larger proportions of specimens obtained from children tested in these laboratories.

Summary of Laboratory Testing Results Reported to CDC*

Week 19 (May 3 – May 9, 2020)

Cumulative since March 1, 2020

No. of specimens tested 955,714 6,012,947

Public Health Laboratories 131,841 836,543

Clinical Laboratories 81,269 494,880

Commercial Laboratories 742,604 4,681,524

No. of positive specimens (%) 97,237 (10.1%) 945,395 (15.7%)

Public Health Laboratories 15,501 (11.8%) 124,473 (14.9%)

Clinical Laboratories 5,641 (6.9%) 45,312 (9.2%)

Commercial Laboratories 76,095 (10.2%) 775,610 (16.6%)

* Commercial and clinical laboratory data represents select laboratories and does not capture all tests performed in the United States.


Public Health Laboratories

Clinical Laboratories


Commercial Laboratories

* Commercial laboratories began testing for SARS-CoV-2 in early March, but the number and geographic distribution of reporting

commercial laboratories became stable enough to calculate a weekly percentage of specimens testing positive as of March 29, 2020.

Additional virologic surveillance information: Surveillance Methods Outpatient/Emergency Department Illness Two syndromic surveillance systems are being used to monitor trends in outpatient and emergency department visits that may be associated with COVID-19. Each system monitors a slightly different syndrome, and together these systems provide a more comprehensive picture of mild to moderate COVID-19 illness than either would individually. Both systems are currently being affected by recent changes in healthcare seeking behavior, including increased use of telemedicine, recommendations to limit emergency department (ED) visits to severe illnesses, and increased practice of social distancing. These changes affect the numbers of people and their reasons for seeking care in the outpatient and ED settings. ILINet The U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) provides data on visits for influenza-like illness (ILI) (fever [≥100○F] and cough and/or sore throat) to approximately 2,600

primary care providers, emergency departments and urgent care centers in all 50 states, Puerto Rico, the District of Columbia and the U.S. Virgin Islands. Mild COVID-19 illness presents with symptoms similar to ILI, so ILINet is being used to track trends of mild to moderate COVID-19 illness and allows for comparison with prior influenza seasons.

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#virologic


Nationwide during week 19, 1.2% of patient visits reported through ILINet were due to ILI. This percentage is below the national baseline of 2.4% and represents the seventh week of decline after three weeks of increase beginning in early March. The percentage of visits for ILI decreased in all age groups. Nationally, laboratory-confirmed influenza activity as reported by clinical laboratories has decreased to levels usually seen in summer months which, along with changes in healthcare seeking behavior and the impact of social distancing, is likely contributing to the decrease in ILI activity.

On a regional level, the percentage of outpatient visits for ILI ranged from 0.6% to 2.0% during week 19. Compared to week 18, the percent of outpatient visits for ILI was unchanged in region 9, but decreased in all other regions, and all ten regions are below their region-specific baselines. ILI Activity Levels Data collected in ILINet are used to produce a measure of ILI activity for all 50 states, Puerto Rico, the District of Columbia and New York City. The mean reported percentage of visits due to ILI for the current week is compared to the mean reported during non-influenza weeks, and the activity levels correspond to the number of standard deviations below, at or above the mean. The number of jurisdictions at each activity level during week 19 and the change compared to the previous week are summarized in the table below and shown in the following maps. The decreasing percentage of visits for ILI described above are reflected in this week’s ILI activity levels.

* Age-group specific percentages should not be compared to the national baseline.

https://www.cdc.gov/flu/weekly/#ClinicalLaboratories

https://www.hhs.gov/about/agencies/iea/regional-offices/index.html

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html


Activity Level

Number of Jurisdictions

Week 19 (Week ending May 9, 2020)

Compared to Previous Week

Very High 0 No change

High 1 -1

Moderate 2 No change

Low 2 -2

Minimal 48 +3

Insufficient Data 1 No change

National Syndromic Surveillance Program (NSSP): Emergency Department (ED) Visits NSSP is a collaboration among CDC, federal partners, local and state health departments and academic and private sector partners to collect, analyze and share electronic patient encounter data received from multiple healthcare settings. To track trends of potential COVID-19 visits, visits for COVID-19-like illness (CLI) (fever and cough or shortness of breath or difficulty breathing or presence of a coronavirus diagnosis code) and ILI to a subset of emergency departments in 47 states are being monitored. Nationwide during week 19, 2.8% of emergency department visits captured in NSSP were due to CLI and 0.9% were due to ILI. This is the seventh week of decline in percentage of visits for ILI and the sixth week of stable or declining percentage of visits for CLI. All 10 HHS regions experienced a decline in percentage of visits for ILI and CLI.

*Data collected in ILINet may disproportionally represent certain populations within a state and may not accurately depict the full picture of influenza activity for the whole state. Differences in the data presented here by CDC and independently by some state health departments likely represent differing levels of data completeness with data presented by the state likely being the more complete.

ILI Activity Level Map, Week 18, Ending May 2, 2020 ILI Activity Level Map, Week 19, Ending May 9, 2020

https://www.hhs.gov/about/agencies/iea/regional-offices/index.html


Additional information about medically attended outpatient and emergency department visits for ILI and CLI: Surveillance Methods Hospitalizations The COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) conducts population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in select counties participating in the Emerging Infections Program (EIP) and states participating in the Influenza Hospitalization Surveillance Project (IHSP). COVID-NET-estimated hospitalization rates are updated weekly. A total of 19,637 laboratory-confirmed COVID-19-associated hospitalizations were reported by sites between March 1, 2020, and May 9, 2020. The overall cumulative hospitalization rate was 60.5 per 100,000 population. Among the 0-4 years, 5-17 years, 18-49 years, 50-64 years, and ≥ 65 years age groups, the highest rate of hospitalization is among adults aged ≥ 65 years (192.4 per 100,000), followed by adults aged 50-64 years (94.4 per 100,000) and adults aged 18-49 years (32.6 per 100,000).

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#outpatient


Within the 18-49 years and ≥ 65 years age groups, the hospitalization rates increased with increasing

age.

Age Group Cumulative Rate per 100,000 Population

Overall 60.5

0-4 years 3.0

5-17 years 1.4

18-49 years 32.6

18-29 years 15.4

30-39 years 32.0

40-49 years 55.6

50-64 years 94.4

65+ years 192.4

65-74 years 141.2

75-84 years 232.0

85+ years 352.0


Among 13,441 cases with information on race/ethnicity, 36.5% were non-Hispanic white, 40.0% were non-Hispanic black, 14.2% were Hispanic, and 9.3% were other race.

Race

Overall

N (%) 0-4 years N (%)

5-17 years N (%)

18-49 years N (%)

50-64 years N (%)

65+ years

N (%)

Cases with available race

13441 (68.4) 29 (50.0) 46 (62.2) 2987 (63.6) 3947 (67.5) 6432 (71.8)

NH White 4908 (36.5) 7 (24.1) 8 (17.4) 568 (19.0) 1159 (29.4) 3166 (49.2)

NH Black 5372 (40.0) 9 (31.0) 16 (34.8) 1165 (39.0) 1780 (45.1) 2402 (37.3)

Hispanic 1906 (14.2) 7 (24.1) 19 (41.3) 898 (30.1) 616 (15.6) 366 (5.7)

Other1 1255 (9.3) 6 (20.7) 3 (6.5) 356 (11.9) 392 (9.9) 498 (7.7)

Cases missing race2

6196 (31.6) 29 (50.0) 28 (37.8) 1708 (36.4) 1904 (32.5) 2527 (28.2)

1 Other includes data on persons who are Asian, American Indian/Alaskan Native, Multi-race, and persons for whom race/ethnicity data is unknown; 2 Cases with missing race include those for whom chart reviews have not yet been conducted to ascertain race; these data will be updated as additional race data become available; NH=non-Hospanic

Among 3,734 hospitalized adults with information on underlying medical conditions, 91.7% had at least one reported underlying medical condition, the most commonly reported were hypertension, obesity, chronic metabolic disease, and cardiovascular disease.


Additional hospitalization surveillance information: Surveillance Methods | Additional rate data | Additional demographic and clinical data

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#hospitalization

https://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html

https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html


Mortality Surveillance The National Center for Health Statistics (NCHS) collects death certificate data from vital statistics offices for all deaths occurring in the United States. Based on death certificate data available on May 14, 2020, 12.8% of all deaths occurring during the week ending May 9, 2020 (week 19) were due to pneumonia, influenza or COVID-19 (PIC). This is the third week of a declining percentage of deaths due to PIC; however, the percentage remains above the epidemic threshold of 6.6% for week 19. Data for recent weeks are incomplete, and the PIC percentage may increase as more death certificates representing deaths during these weeks are filed. Weekly mortality surveillance data include a combination of machine coded and manually coded causes of death collected from death certificates. Percentages of deaths due to PIC are higher among manually coded records than more rapidly available machine coded records. Due to the additional time needed for manual coding, the initially reported PIC percentages may be lower than percentages calculated from final data. Given the amount of manually coded data available for deaths occurring during week 19, it is possible that when additional death certificates are processed, the week 19 PIC percentage may be greater than what was reported for week 18.

*Data during recent weeks are incomplete because of the lag in time between when the death occurred and when the death

certificate is completed, submitted to NCHS and processed for reporting purposes.

Additional NCHS mortality surveillance information: Surveillance Methods | Provisional Death Counts for COVID-19

Report prepared: May 14, 2020

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#mortality

https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm

https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm


U.S. State and Local Public Health Laboratories Reporting to CDC

March 1, 2020 - May 9, 2020

Data as of May 14, 2020

National

Week No. of

Labs

Total (includes age unknown) 0-4 years 5-17 years 18-49 years 50-64 years 65+ years

Spec Tested # Pos

% Pos

Spec Test-

ed #

Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202010 76 8,406 1,023 12.2 207 10 4.8 559 39 7.0 2,930 294 10.0 1,804 238 13.2 1,916 299 15.6

202011 83 36,460 3,687 10.1 922 19 2.1 1,866 78 4.2 14,741 1,294 8.8 7,876 922 11.7 7,367 877 11.9

202012 84 70,466 6,993 9.9 1,491 34 2.3 2,239 81 3.6 30,536 2,565 8.4 15,336 1,746 11.4 15,393 2,026 13.2

202013 85 67,682 11,085 16.4 1,177 46 3.9 1,352 79 5.8 27,818 3,628 13.0 14,525 2,802 19.3 16,599 3,699 22.3

202014 86 80,707 14,393 17.8 1,069 59 5.5 1,397 162 11.6 32,672 4,226 12.9 17,723 3,483 19.7 21,188 5,355 25.3

202015 85 84,142 15,561 18.5 867 40 4.6 1,538 154 10.0 32,619 4,078 12.5 18,620 3,423 18.4 23,307 6,353 27.3

202016 83 82,196 15,527 18.9 680 59 8.7 1,129 121 10.7 33,072 4,955 15.0 17,219 3,086 17.9 23,608 5,918 25.1

202017 81 128,296 21,497 16.8 813 48 6 2,334 318 13.6 55,466 8,223 14.8 27,325 4,501 16.5 34,933 7,044 20.2

202018 81 146,347 19,206 13.1 1,047 90 8.6 3,407 417 12.2 60,015 7,415 12.4 31,350 3,820 12.2 39,652 5,963 15.0

202019 79 131,841 15,501 11.8 1,321 75 5.7 3,160 407 12.9 55,856 6,527 11.7 29,532 3,066 10.4 35,317 4,650 13.2

Total

676,488

106,529 15.7

7,953 393 4.9 15,327 1,410 9.2 274,608 35,815 13.0 147,684 23,552 15.9 178,962 36,809 20.6

Region 1 (CT, ME, MA, NH, RI, VT)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 8 715 142 19.9 202011 16 3,306 282 8.5 202012 17 9,616 732 7.6 202013 15 4,635 700 15.1 202014 15 6,167 1,622 26.3 202015 17 8,242 2,424 29.4 202016 13 11,652 2,652 22.8 202017 11 17,153 2,982 17.4 202018 12 11,248 1,808 16.1 202019 9 8,562 1,483 17.3

Total 81,296 14,827 18.2


Region 2 (NJ, NY, PR)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 6 1,434 193 13.5 202011 20 5,416 788 14.6 202012 25 10,496 1,442 13.7 202013 21 6,762 2,250 33.3 202014 22 7,054 2,288 32.4 202015 17 6,411 1,707 26.6 202016 18 5,075 1,243 24.5 202017 17 5,813 1,049 18.1 202018 18 7,540 953 12.6 202019 14 9,284 836 9.0

Total 65,285 12,749 19.5

Region 3 (DE, DC, MD, PA, VA, WV)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 8 334 30 9.0 202011 20 1,489 208 14.0 202012 22 2,543 356 14.0 202013 18 4,138 780 18.9 202014 18 5,532 1,340 24.2 202015 18 5,337 1,835 34.4 202016 21 4,973 1,838 37.0 202017 16 6,151 2,079 33.8 202018 15 7,051 1,663 23.6 202019 17 4,816 1,124 23.3

Total 42,364 11,253 26.6

Region 4 (AL, FL, GA, KY, MS, NC, SC, TN)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 16 757 69 9.1 202011 28 4,478 449 10.0 202012 35 10,838 1,000 9.2 202013 28 12,568 1,723 13.7 202014 29 14,917 2,119 14.2 202015 29 17,884 2,659 14.9 202016 26 14,100 2,187 15.5 202017 24 17,544 2,623 15.0 202018 24 18,558 2,602 14.0 202019 28 20,641 2,189 10.6

Total 132,285 17,620 13.3


Region 5 (IL, IN, MI, MN, OH, WI)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 18 759 35 4.6 202011 27 7,064 492 7.0 202012 31 12,229 1,226 10.0 202013 27 12,146 2,654 21.9 202014 27 14,474 3,067 21.2 202015 29 14,278 2,772 19.4 202016 22 12,072 2,209 18.3 202017 22 23,227 5,099 22.0 202018 19 39,273 6,093 15.5 202019 19 32,603 4,585 14.1

Total 168,125 28,232 16.8

Region 6 (AR, LA, NM, OK, TX)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 9 278 11 4.0 202011 21 2,765 328 11.9 202012 30 4,493 863 19.2 202013 29 4,777 850 17.8 202014 27 5,989 1,005 16.8 202015 22 5,634 909 16.1 202016 22 4,260 895 21.0 202017 21 11,216 1,043 9.3 202018 21 13,764 1,146 8.3 202019 19 18,588 1,248 6.7

Total 71,764 8,298 11.6

Region 7 (IA, KS, MO, NE)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 7 268 43 16.0 202011 14 1,106 70 6.3 202012 17 2,918 148 5.1 202013 12 3,665 330 9.0 202014 14 4,547 513 11.3 202015 11 5,746 704 12.3 202016 11 7,680 1,677 21.8 202017 12 15,101 3,786 25.1 202018 10 10,687 2,206 20.6 202019 16 13,044 2,322 17.8

Total 64,762 11,799 18.2


Region 8 (CO, MT, ND, SD, UT, WY)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 7 561 28 5.0 202011 13 4,229 346 8.2 202012 14 7,638 352 4.6 202013 15 7,543 390 5.2 202014 12 8,742 613 7.0 202015 13 7,800 451 5.8 202016 12 7,743 662 8.6 202017 14 14,454 960 6.6 202018 14 18,855 569 3.0 202019 16 9,026 479 5.3

Total 86,591 4,850 5.6

Region 9 (AZ, CA, GU, HI, NV)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 25 1,719 200 11.6 202011 38 4,922 629 12.8 202012 45 6,574 625 9.5 202013 42 8,284 1,108 13.4 202014 40 9,596 1,486 15.5 202015 38 9,574 1,881 19.7 202016 32 9,606 1,872 19.5 202017 31 13,099 1,656 12.6 202018 28 14,918 1,840 12.3 202019 29 9,672 926 9.6

Total 87,964 12,223 13.9

Region 10 (AK, ID, OR, WA)

Week No. of

Labs

Spec Tested

# Pos %

Pos

202010 8 1,581 272 17.2 202011 17 1,685 95 5.6 202012 14 3,121 249 8.0 202013 11 3,164 300 9.5 202014 14 3,689 340 9.2 202015 9 3,236 219 6.8 202016 9 5,035 292 5.8 202017 9 4,538 220 4.9 202018 11 4,453 326 7.3 202019 11 5,605 309 5.5

Total 36,107 2,622 7.3


U.S. Clinical Laboratories Reporting SARS-CoV-2 Test Results to CDC

March 8, 2020 - May 9, 2020


National

Week Number of Labs

Reporting Spec Tested # Pos % Pos

202011 26 2,486 146 5.9

202012 42 18,674 1,153 6.2

202013 54 43,375 3,545 8.2

202014 62 53,087 5,459 10.3

202015 80 53,634 6,433 12.0

202016 94 64,530 6,802 10.5

202017 100 82,686 8,183 9.9

202018 102 95,139 7,950 8.4

202019 67 81,269 5,641 6.9

Total 494,880 45,312 9.2


U.S. Commercial Laboratories Reporting to CDC

March 29, 2020 – May 9, 2020 Data as of May 14, 2020

National

Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 540,530 124,987 23.1 8,287 529 6.4 13,464 1,860 13.8 288,261 60,971 21.2 130,001 35,049 27.0 75,801 20,976 27.7

202015 6 501,026 114,237 22.8 6,747 599 8.9 12,876 2,152 16.7 258,282 55,269 21.4 124,218 31,651 25.5 73,176 19,205 26.2

202016 6 506,808 98,430 19.4 6,358 577 9.1 15,083 2,352 15.6 241,600 46,063 19.1 122,205 24,845 20.3 78,775 16,132 20.5

202017 6 611,656 97,173 15.9 7,725 684 8.9 19,629 2,982 15.2 294,375 48,505 16.5 151,636 24,010 15.8 109,662 16,776 15.3

202018 6 733,683 95,192 13.0 9,774 830 8.5 24,373 3,606 14.8 347,312 48,666 14.0 179,103 22,021 12.3 136,532 15,842 11.6

202019 6 742,604 76,095 10.2 9,705 773 8.0 23,936 3,161 13.2 316,775 36,940 11.7 165,568 15,778 9.5 136,663 11,767 8.6

Total 3,636,307 606,114 16.7 48,596 3,992 8.2 109,361 16,113 14.7 1,746,605 296,414 17.0 872,731 153,354 17.6 610,609 100,698 16.5


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 42,060 10,445 24.8 473 34 7.2 824 157 19.1 21,461 4,900 22.8 10,981 2,950 26.9 6,580 1,986 30.2

202015 6 41,135 10,588 25.7 450 43 9.6 926 182 19.7 20,086 4,846 24.1 11,103 2,909 26.2 6,656 2,104 31.6

202016 6 41,026 10,329 25.2 424 74 17.5 1,111 229 20.6 17,803 4,321 24.3 9,594 2,320 24.2 6,383 1,871 29.3

202017 5 51,286 10,415 20.3 559 98 17.5 1,626 333 20.5 24,824 4,988 20.1 13,165 2,448 18.6 8,919 2,098 23.5

202018 6 64,641 10,517 16.3 668 93 13.9 1,918 388 20.2 31,576 5,007 15.9 16,175 2,364 14.6 11,672 2,262 19.4

202019 6 66,688 9,269 13.9 579 81 14.0 1,697 327 19.3 25,713 3,683 14.3 13,664 1,744 12.8 11,626 1,777 15.3

Total 306,836 61,563 20.1 3,153 423 13.4 8,102 1,616 19.9 141,463 27,745 19.6 74,682 14,735 19.7 51,836 12,098 23.3


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 134,853 66,721 49.5 1,417 332 23.4 3,130 1,117 35.7 71,236 32,701 45.9 35,713 18,955 53.1 17,631 10,753 61.0

202015 6 142,471 62,909 44.2 1,426 355 24.9 3,878 1,309 33.8 74,301 30,506 41.1 38,855 18,148 46.7 17,850 9,839 55.1

202016 6 133,822 47,059 35.2 1,259 239 19.0 4,447 1,215 27.3 66,473 21,978 33.1 35,683 12,947 36.3 17,049 7,276 42.7

202017 6 143,872 39,233 27.3 1234 149 12.1 4,712 1145 24.3 70,028 18,586 26.5 39,050 10,714 27.4 22,360 6,917 30.9

202018 6 151,749 30,416 20.0 1,440 172 11.9 5,228 1,039 19.9 72,118 14,638 20.3 40,761 7,962 19.5 25,460 5,249 20.6

202019 6 145,967 20,615 14.1 1,241 128 10.3 4,932 728 14.8 65,397 9,449 14.4 38,239 5,177 13.5 26,830 3,993 14.9

Total 852,734 266,953 31.3 8,017 1,375 17.2 26,327 6,553 24.9 419,553 127,858 30.5 228,301 73,903 32.4 127,180 44,027 34.6



Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 94,455 10,243 10.8 1,430 35 2.4 2,168 96 4.4 49,533 4,815 9.7 22,465 2,830 12.6 14,646 1,976 13.5

202015 6 80,339 8,159 10.2 916 37 4.0 1,703 107 6.3 40,080 3,884 9.7 19,667 2,167 11.0 13,406 1,484 11.1

202016 6 98,199 8,706 8.9 1,106 40 3.6 2,663 223 8.4 43,368 4,123 9.5 24,984 2,083 8.3 18,619 1,469 7.9

202017 6 109,154 8,966 8.2 1353 70 5.2 3,228 231 7.2 48,359 4,511 9.3 28,058 2,151 7.7 23,318 1,635 7.0

202018 6 131,817 9,487 7.2 1,648 80 4.9 3,801 357 9.4 57,037 4,888 8.6 33,883 2,115 6.2 29,749 1,673 5.6

202019 6 123,020 7,425 6.0 1,478 53 3.6 3,204 264 8.2 47,409 3,693 7.8 28,556 1,484 5.2 28,308 1,141 4.0

Total 636,984 52,986 8.3 7,931 315 4.0 16,767 1,278 7.6 285,786 25,914 9.1 157,613 12,830 8.1 128,046 9,378 7.3


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 42,124 7,820 18.6 670 8 1.2 791 50 6.3 22,131 3,647 16.5 10,116 2,220 21.9 6,642 1,513 22.8

202015 6 35,556 5,935 16.7 555 7 1.3 649 40 6.2 18,057 2,858 15.8 8,837 1,658 18.8 5,900 1,087 18.4

202016 6 33,969 5,240 15.4 516 28 5.4 734 66 9.0 16,264 2,332 14.3 8,028 1,349 16.8 5,806 1,021 17.6

202017 6 50,356 7,079 14.1 722 39 5.4 1,308 181 13.8 25,085 3,685 14.7 12,619 1,691 13.4 8,591 1228 14.3

202018 6 70,859 9,937 14.0 1,060 71 6.7 1,986 309 15.6 35,050 5,354 15.3 17,342 2,250 13.0 12,267 1,533 12.5

202019 6 91,587 8,813 9.6 1,259 99 7.9 2,449 375 15.3 38,343 4,366 11.4 19,899 1,694 8.5 14,707 1,079 7.3

Total 324,451 44,824 13.8 4,782 252 5.3 7,917 1,021 12.9 154,930 22,242 14.4 76,841 10,862 14.1 53,913 7,461 13.8


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 56,458 10,649 18.9 922 32 3.5 1,283 147 11.5 30,583 5,419 17.7 13,645 3,002 22.0 7,300 1,580 21.6

202015 6 51,460 10,930 21.2 749 48 6.4 1,131 179 15.8 26,617 5,397 20.3 12,608 2,925 23.2 7,288 1,797 24.7

202016 6 50,924 11,520 22.6 700 79 11.3 1,186 209 17.6 24,526 5,553 22.6 11,542 2,636 22.8 7,634 1,937 25.4

202017 6 77,726 12,711 16.4 913 124 13.6 1,724 394 22.9 38,032 6,652 17.5 18,396 2,833 15.4 15,276 2,218 14.5

202018 6 84,424 14,416 17.1 1,109 180 16.2 2,356 527 22.4 42,064 7,789 18.5 18,905 2,991 15.8 14,120 2,206 15.6

202019 6 84,636 12,307 14.5 1,140 194 17.0 2,384 544 22.8 40,050 6,749 16.9 18,234 2,342 12.8 12,718 1,494 11.7

Total 405,628 72,533 17.9 5,533 657 11.9 10,064 2,000 19.9 201,872 37,559 18.6 93,330 16,729 17.9 64,336 11,232 17.5



Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 62,240 8,486 13.6 1,325 42 3.2 1,960 128 6.5 34,575 4,319 12.5 13,273 2,278 17.2 7,240 1,182 16.3

202015 6 56,462 6,454 11.4 1,092 53 4.9 1,774 165 9.3 30,287 3,319 11.0 11,973 1,613 13.5 6,955 942 13.5

202016 6 62,449 6,421 10.3 1030 63 6.1 2,110 192 9.1 31,526 3,445 10.9 13,605 1,455 10.7 8,822 809 9.2

202017 6 72,292 7,242 10.0 1254 88 7.0 2,953 296 10.0 36,483 4,089 11.2 15,818 1,572 9.9 10,836 765 7.1

202018 6 87,821 7,431 8.5 1,585 103 6.5 3,558 385 10.8 42,690 4,160 9.7 19,412 1,531 7.9 14,559 835 5.7

202019 6 80,934 5,968 7.4 1,491 82 5.5 3,011 280 9.3 33,780 3,144 9.3 15,318 1,121 7.3 13,149 597 4.5

Total 422,198 42,002 9.9 7,777 431 5.5 15,366 1,446 9.4 209,341 22,476 10.7 89,399 9,570 10.7 61,561 5,130 8.3


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 12,537 1,389 11.1 291 6 2.1 358 17 4.7 6,691 633 9.5 2,947 436 14.8 1,727 240 13.9

202015 5 10,463 1,032 9.9 197 2 1.0 310 12 3.9 5,543 546 9.9 2,456 293 11.9 1,493 145 9.7

202016 6 11,190 1,530 13.7 212 4 1.9 289 26 9.0 5,449 783 14.4 2,328 344 14.8 1,510 206 13.6

202017 5 16,447 3,050 18.5 314 31 9.9 638 106 16.6 8,727 1,715 19.7 3,721 768 20.6 2,342 304 13.0

202018 6 24,068 3,234 13.4 427 38 8.9 994 174 17.5 11,704 1,854 15.8 5,670 741 13.1 4,099 289 7.1

202019 6 24,295 2,198 9.0 414 26 6.3 903 101 11.2 10,852 1,213 11.2 5,146 421 8.2 4,304 225 5.2

Total 99,000 12,433 12.6 1,855 107 5.8 3,492 436 12.5 48,966 6,744 13.8 22,268 3,003 13.5 15,475 1,409 9.1


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 20,150 1,984 9.8 499 13 2.6 849 33 3.9 12,238 1,134 9.3 3,690 449 12.2 2,063 280 13.6

202015 6 12,897 1,510 11.7 289 9 3.1 500 30 6.0 7,221 803 11.1 2,461 340 13.8 1,817 270 14.9

202016 6 11,037 1,023 9.3 194 8 4.1 482 16 3.3 5,778 533 9.2 2,150 202 9.4 1,366 111 8.1

202017 6 13,769 1,377 10.0 272 14 5.1 665 53 8.0 7,336 809 11.0 2,982 288 9.7 1,792 122 6.8

202018 6 15,720 1,456 9.3 352 17 4.8 845 68 8.0 8,012 817 10.2 3,267 278 8.5 2,361 193 8.2

202019 6 21,913 2,129 9.7 468 27 5.8 1,452 161 11.1 10,410 1,110 10.7 4,103 354 8.6 3,013 163 5.4

Total 95,486 9,479 9.9 2,074 88 4.2 4,793 361 7.5 50,995 5,206 10.2 18,653 1,911 10.2 12,412 1,139 9.2


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 56,403 5,887 10.4 860 22 2.6 1,456 84 5.8 28,959 2,700 9.3 12,878 1,567 12.2 9,653 1,267 13.1

202015 6 52,672 5,480 10.4 771 38 4.9 1,480 102 6.9 26,502 2,485 9.4 12,240 1,291 10.5 9,378 1,332 14.2

202016 6 51,372 5,600 10.9 684 38 5.6 1,594 136 8.5 23,762 2,492 10.5 11,424 1,256 11.0 9,698 1,284 13.2

202017 6 62,319 6,062 9.7 860 63 7.3 2,298 221 9.6 28,043 2,876 10.3 14,579 1,302 8.9 13,811 1,360 9.8

202018 6 88,271 7,309 8.3 1,217 68 5.6 3,129 303 9.7 39,841 3,572 9.0 20,562 1,612 7.8 19,689 1,481 7.5

202019 6 88,433 6,480 7.3 1,377 71 5.2 3,399 339 10.0 37,700 3,026 8.0 19,287 1,265 6.6 19,221 1,208 6.3

Total 399,470 36,818 9.2 5,769 300 5.2 13,356 1,185 8.9 184,807 17,151 9.3 90,970 8,293 9.1 81,450 7,932 9.7



Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Test-

ed # Pos %

Pos

Spec Test-

ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Test-ed # Pos %

Pos Spec

Tested # Pos %

Pos

202014 6 19,125 1,363 7.1 399 5 1.3 645 31 4.8 10,778 703 6.5 4,252 362 8.5 2,314 199 8.6

202015 6 17,556 1,240 7.1 302 7 2.3 524 26 5.0 9,582 625 6.5 4,012 307 7.7 2,432 205 8.4

202016 6 12,806 1,002 7.8 233 4 1.7 466 40 8.6 6,643 503 7.6 2,864 253 8.8 1,887 148 7.8

202017 6 14,345 1038 7.2 242 8 3.3 473 22 4.7 7,431 594 8.0 3,226 243 7.5 2,389 129 5.4

202018 6 14,247 988 6.9 268 8 3.0 557 56 10.1 7,189 586 8.2 3,114 177 5.7 2,537 121 4.8

202019 6 15,087 891 5.9 257 12 4.7 505 42 8.3 7,096 507 7.1 3,112 176 5.7 2,782 90 3.2

Total 93,166 6,522 7.0 1,701 44 2.6 3,170 217 6.8 48,719 3,518 7.2 20,580 1,518 7.4 14,341 892 6.2


U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet): Overall Percentage of Visits for ILI

September 29, 2019 - May 9, 2020


National (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 2,912 6,240 7,679 4,824 1,773 1,445 21,961 1,460,252 1.5 1.5

201941 2,943 6,573 7,638 5,146 2,022 1,601 22,980 1,438,727 1.6 1.6

201942 2,967 7,304 8,295 5,551 2,115 1,647 24,912 1,432,866 1.7 1.7

201943 2,998 7,894 9,367 6,075 2,310 1,794 27,440 1,475,680 1.9 1.8

201944 3,007 8,678 10,060 6,134 2,284 1,758 28,914 1,437,828 2.0 2.0

201945 3,022 10,561 12,501 7,161 2,464 1,839 34,526 1,464,860 2.4 2.4

201946 2,990 11,424 13,533 7,853 2,743 1,965 37,518 1,428,594 2.6 2.6

201947 2,986 12,659 16,866 9,062 3,103 2,135 43,825 1,486,871 2.9 2.9

201948 2,994 14,363 14,669 9,114 3,206 2,358 43,710 1,277,556 3.4 3.4

201949 2,996 13,795 16,275 11,862 3,940 2,774 48,646 1,478,190 3.3 3.3

201950 2,958 14,672 21,797 12,778 4,135 2,899 56,281 1,460,619 3.9 3.9

201951 2,926 17,992 29,110 16,224 4,846 3,348 71,520 1,426,233 5.0 5.1

201952 2,918 24,058 33,951 24,593 7,660 5,400 95,662 1,341,111 7.1 7.1

202001 2,966 21,588 23,403 27,633 9,229 6,864 88,717 1,427,751 6.2 5.9

202002 2,996 15,520 22,687 23,551 8,197 5,450 75,405 1,489,798 5.1 4.9

202003 2,986 16,498 29,540 21,347 7,376 4,726 79,487 1,485,642 5.4 5.3

202004 2,988 18,501 35,166 23,539 7,963 4,646 89,815 1,494,896 6.0 6.1

202005 2,984 20,184 43,934 28,713 9,519 5,450 107,800 1,569,390 6.9 6.7

202006 2,992 20,127 45,346 29,699 10,039 5,667 110,878 1,566,079 7.1 6.8

202007 2,955 17,237 36,719 26,253 9,214 5,416 94,839 1,526,113 6.2 6.1

202008 2,970 15,192 28,332 23,022 8,313 5,154 80,013 1,425,794 5.6 5.5

202009 2,924 13,644 25,250 21,917 8,256 5,058 74,125 1,454,545 5.1 5.1

202010 2,889 13,699 26,194 23,686 8,871 5,650 78,100 1,477,884 5.3 5.3

202011 2,812 13,939 27,552 29,485 11,311 6,657 88,944 1,406,681 6.3 5.7

202012 2,764 10,669 17,401 30,711 12,477 6,951 78,209 1,054,892 7.4 6.4

202013 2,675 5,079 8,266 22,358 10,825 6,419 52,947 841,271 6.3 4.9

202014 2,626 2,355 4,841 14,909 8,686 5,367 36,158 737,121 4.9 3.8

202015 2,615 1,453 3,381 9,930 6,022 3,999 24,785 702,316 3.5 2.8

202016 2,594 1,028 2,603 7,360 4,162 2,897 18,050 692,214 2.6 2.1

202017 2,564 891 2,271 6,294 3,260 2,277 14,993 730,730 2.1 1.7

202018 2,497 850 2,075 5,247 2,651 1,873 12,696 768,136 1.7 1.5

202019 2,329 669 1,787 4,306 2,135 1,550 10,447 751,752 1.4 1.2

Totals 1,774,303 41,212,392


HHS Region 1 (CT, ME, MA, NH, RI, and VT) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 255 247 404 324 174 112 1,261 130,089 1.0 .9

201941 261 274 441 396 178 176 1,465 130,676 1.1 1.0

201942 265 313 501 436 179 163 1,592 129,402 1.2 1.1

201943 262 318 513 400 187 153 1,571 133,141 1.2 1.1

201944 271 333 570 389 187 164 1,643 132,506 1.2 1.1

201945 263 390 662 456 162 140 1,810 131,409 1.4 1.3

201946 261 463 681 470 197 136 1,947 127,939 1.5 1.4

201947 264 537 744 515 227 153 2,176 131,725 1.7 1.5

201948 263 621 700 497 216 191 2,225 111,608 2.0 1.8

201949 264 604 742 633 268 225 2,472 124,372 2.0 1.8

201950 263 631 881 630 269 218 2,629 130,387 2.0 1.9

201951 262 844 1,085 819 300 242 3,290 124,306 2.6 2.5

201952 264 946 1,448 1,278 489 402 4,563 115,551 3.9 3.7

202001 263 980 1,378 1,834 675 525 5,392 126,621 4.3 3.9

202002 270 821 1,618 1,707 690 473 5,309 135,907 3.9 3.7

202003 268 976 2,403 1,762 641 427 6,209 132,162 4.7 4.5

202004 265 1,109 3,149 2,156 776 446 7,636 134,954 5.7 5.3

202005 267 1,253 4,226 2,932 947 593 9,951 146,905 6.8 6.4

202006 266 1,328 4,749 3,147 1,056 610 10,890 143,279 7.6 7.2

202007 265 1,147 3,800 2,836 907 568 9,258 139,224 6.6 6.5

202008 267 989 2,741 2,406 956 597 7,689 129,858 5.9 5.7

202009 258 806 2,027 2,081 852 539 6,305 132,058 4.8 4.6

202010 261 758 1,903 1,921 829 523 5,934 128,729 4.6 4.3

202011 243 678 1,831 2,135 873 644 6,161 114,611 5.4 4.9

202012 242 501 1,057 1,963 919 559 4,999 75,469 6.6 5.9

202013 231 192 461 1,356 751 553 3,313 60,437 5.5 4.8

202014 229 76 319 1,151 688 498 2,732 55,409 4.9 4.4

202015 224 44 227 804 553 397 2,025 53,538 3.8 3.4

202016 231 31 214 776 487 375 1,883 54,771 3.4 3.1

202017 215 15 131 542 338 258 1,284 55,424 2.3 2.1

202018 210 33 150 424 212 215 1,034 57,026 1.8 1.7

202019 207 25 123 366 211 164 889 60,831 1.5 1.4

Totals 127,537 3,590,324


HHS Region 2 (NJ, NY, PR, and USVI) (Baseline: 3.2%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 263 945 884 642 242 281 2,994 195,431 1.5 2.1

201941 263 969 833 651 284 244 2,981 191,446 1.6 2.1

201942 264 1,187 919 675 313 266 3,360 190,590 1.8 2.4

201943 264 1,133 966 687 306 279 3,371 196,090 1.7 2.0

201944 263 1,368 1,050 700 294 285 3,697 190,727 1.9 2.3

201945 268 1,656 1,197 731 317 294 4,195 193,040 2.2 2.4

201946 259 1,739 1,214 776 362 300 4,391 189,305 2.3 2.7

201947 263 1,775 1,360 874 408 284 4,701 197,786 2.4 2.7

201948 265 2,194 1,513 924 428 311 5,370 178,473 3.0 3.3

201949 264 2,260 1,743 1,134 469 381 5,987 193,324 3.1 3.2

201950 260 2,403 2,456 1,397 517 372 7,145 198,649 3.6 3.7

201951 265 2,791 3,466 1,644 645 452 8,998 195,553 4.6 4.8

201952 256 3,543 4,398 2,823 998 733 12,495 190,159 6.6 6.7

202001 258 3,620 3,439 3,653 1,309 994 13,015 197,051 6.6 6.8

202002 260 2,670 3,356 3,284 1,192 826 11,328 192,914 5.9 6.2

202003 263 2,993 4,911 3,057 1,167 775 12,903 198,476 6.5 6.8

202004 258 3,487 6,026 3,476 1,270 813 15,072 205,644 7.3 7.6

202005 262 3,391 6,742 3,856 1,288 844 16,121 210,325 7.7 7.8

202006 268 3,225 6,823 3,516 1,290 829 15,683 210,836 7.4 7.9

202007 255 2,687 5,076 2,817 1,072 724 12,376 196,848 6.3 6.8

202008 256 2,203 3,120 2,445 917 656 9,341 181,354 5.2 5.9

202009 253 1,828 2,454 2,105 777 592 7,756 183,001 4.2 5.0

202010 254 1,893 2,850 2,584 1,010 647 8,984 180,864 5.0 5.5

202011 250 2,093 4,027 4,567 1,907 1,033 13,627 188,994 7.2 7.6

202012 237 1,395 2,592 7,382 3,265 1,837 16,471 148,863 11.1 11.2

202013 219 604 1,402 7,456 4,370 2,406 16,238 128,419 12.6 11.9

202014 234 257 804 5,227 3,936 2,254 12,478 116,722 10.7 10.5

202015 237 159 548 2,805 2,390 1,611 7,513 100,311 7.5 7.8

202016 239 91 353 1,686 1,350 986 4,466 90,788 4.9 5.2

202017 233 88 276 1,083 737 592 2,776 90,203 3.1 3.5

202018 229 88 223 711 542 392 1,956 92,586 2.1 2.5

202019 192 65 163 461 308 284 1,281 86,106 1.5 2.0

Totals 269,070 5,500,878


HHS Region 3 (DE, DC, MD, PA, VA, and WV) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 416 797 1,055 754 267 182 3,055 234,770 1.3 1.2

201941 423 874 1,137 844 331 250 3,436 237,191 1.4 1.3

201942 418 986 1,118 842 338 270 3,554 227,164 1.6 1.4

201943 431 1,079 1,322 1,044 382 256 4,083 239,162 1.7 1.6

201944 421 1,133 1,338 929 350 251 4,001 234,242 1.7 1.5

201945 429 1,265 1,405 1,069 391 249 4,379 234,584 1.9 1.7

201946 420 1,362 1,630 1,158 415 268 4,833 230,308 2.1 1.9

201947 423 1,567 1,931 1,251 516 298 5,563 241,623 2.3 2.1

201948 421 1,858 1,887 1,346 480 345 5,916 212,108 2.8 2.4

201949 414 1,584 2,155 1,780 549 394 6,462 235,580 2.7 2.4

201950 421 1,960 3,221 2,086 632 453 8,352 238,415 3.5 3.0

201951 421 2,378 4,726 2,728 774 541 11,147 241,177 4.6 3.9

201952 423 3,347 5,743 4,101 1,211 878 15,280 230,061 6.6 5.6

202001 421 3,240 4,229 5,062 1,565 1,190 15,286 247,495 6.2 5.5

202002 424 2,233 3,595 4,047 1,311 901 12,087 247,105 4.9 4.4

202003 426 2,259 4,403 3,677 1,194 764 12,297 245,508 5.0 4.6

202004 420 2,485 5,202 4,099 1,396 735 13,917 239,344 5.8 5.3

202005 425 2,774 6,891 5,385 1,748 872 17,670 256,167 6.9 6.3

202006 424 2,740 7,200 5,763 1,938 1,053 18,694 257,695 7.3 6.5

202007 423 2,593 6,348 5,466 1,889 1,057 17,353 272,338 6.4 5.8

202008 426 2,277 4,986 4,674 1,710 891 14,538 246,032 5.9 5.3

202009 420 2,126 4,702 4,671 1,706 921 14,126 248,312 5.7 5.2

202010 415 2,069 4,777 4,936 1,832 1,100 14,714 262,022 5.6 5.1

202011 413 2,287 4,975 6,060 2,375 1,250 16,947 256,239 6.6 6.1

202012 413 1,788 3,064 5,197 2,074 1,115 13,238 189,433 7.0 6.8

202013 400 880 1,297 3,145 1,402 793 7,517 148,071 5.1 4.9

202014 381 370 799 2,096 1,069 673 5,007 129,270 3.9 3.8

202015 374 270 536 1,743 832 523 3,904 124,559 3.1 3.0

202016 371 159 452 1,464 681 419 3,175 121,224 2.6 2.4

202017 398 129 419 1,440 639 362 2,989 135,382 2.2 2.0

202018 385 121 388 1,386 594 353 2,842 142,141 2.0 1.8

202019 372 97 318 928 471 276 2,090 140,792 1.5 1.4

Totals 288,452 6,945,514


HHS Region 4 (AL, FL, GA, KY, MS, NC, SC, and TN) (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 561 1,794 1,986 1,240 371 286 5,677 334,361 1.7 1.7

201941 558 1,777 1,721 1,223 383 292 5,396 318,499 1.7 1.6

201942 572 1,842 1,879 1,348 400 306 5,775 313,461 1.8 1.8

201943 575 2,125 2,226 1,509 511 366 6,737 322,986 2.1 2.0

201944 581 2,320 2,489 1,523 497 345 7,174 319,836 2.2 2.3

201945 585 2,938 3,183 1,926 565 386 8,998 324,403 2.8 2.9

201946 580 3,171 3,444 2,081 679 427 9,802 313,285 3.1 3.1

201947 567 3,317 4,493 2,505 710 451 11,476 316,541 3.6 3.3

201948 573 4,071 4,319 2,633 854 606 12,483 295,056 4.2 4.2

201949 579 3,850 4,659 3,504 1,055 700 13,768 332,796 4.1 4.0

201950 576 3,960 6,652 3,948 1,188 692 16,440 328,757 5.0 5.0

201951 554 5,268 9,303 5,388 1,462 864 22,285 324,722 6.9 6.4

201952 559 7,503 10,340 8,360 2,545 1,534 30,282 322,120 9.4 8.8

202001 568 5,933 6,167 8,285 2,720 1,815 24,920 331,002 7.5 6.8

202002 569 3,722 5,439 6,293 2,021 1,201 18,676 329,727 5.7 5.2

202003 570 3,902 7,023 5,409 1,776 1,007 19,117 328,520 5.8 5.4

202004 577 4,137 7,577 5,610 1,726 915 19,965 324,157 6.2 6.4

202005 567 4,810 10,127 7,348 2,281 1,141 25,707 342,238 7.5 7.5

202006 571 5,076 10,968 8,022 2,465 1,257 27,788 353,084 7.9 7.3

202007 565 3,872 7,877 6,553 2,152 1,156 21,610 334,617 6.5 6.3

202008 575 3,004 5,591 4,958 1,515 917 15,985 285,966 5.6 5.4

202009 567 2,719 5,292 5,003 1,693 959 15,666 311,824 5.0 4.8

202010 561 3,161 6,135 5,459 1,875 1,031 17,661 326,217 5.4 5.4

202011 539 3,251 6,542 6,776 2,355 1,358 20,282 316,459 6.4 5.8

202012 535 2,792 4,198 6,509 2,427 1,255 17,181 249,789 6.9 5.9

202013 531 1,448 2,089 4,120 1,624 998 10,279 196,939 5.2 4.3

202014 514 705 1,185 2,432 980 704 6,006 166,176 3.6 3.1

202015 505 422 801 1,668 786 552 4,229 157,220 2.7 2.0

202016 495 312 586 1,263 583 422 3,166 156,147 2.0 1.6

202017 481 264 499 1,103 518 410 2,794 162,073 1.7 1.2

202018 472 214 425 920 451 329 2,339 164,827 1.4 1.0

202019 459 195 394 932 392 333 2,246 178,370 1.3 .9

Totals 431,910 9,182,175


HHS Region 5 (IL, IN, MI, MN, OH, and WI) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 394 562 744 356 141 124 1,927 163,595 1.2 1.1

201941 399 651 760 408 180 156 2,155 156,895 1.4 1.3

201942 399 741 839 421 190 143 2,334 161,273 1.4 1.3

201943 413 806 896 509 233 158 2,602 171,818 1.5 1.4

201944 412 800 929 515 197 150 2,591 167,552 1.5 1.4

201945 418 862 977 523 216 167 2,745 171,491 1.6 1.5

201946 419 878 909 549 209 191 2,736 165,341 1.7 1.5

201947 417 938 1,128 548 229 180 3,023 170,781 1.8 1.6

201948 419 1,191 1,021 510 208 175 3,105 147,954 2.1 2.0

201949 420 1,332 1,319 736 283 205 3,875 176,700 2.2 2.1

201950 413 1,468 1,593 743 272 209 4,285 166,539 2.6 2.4

201951 416 1,749 2,058 950 324 233 5,314 155,323 3.4 3.2

201952 411 2,176 2,390 1,399 430 328 6,723 135,026 5.0 4.7

202001 413 2,152 1,735 1,606 528 425 6,446 156,151 4.1 3.5

202002 415 1,621 1,831 1,456 537 348 5,793 166,713 3.5 2.9

202003 414 1,619 2,375 1,283 455 273 6,005 166,523 3.6 3.1

202004 419 1,921 3,411 1,676 505 287 7,800 169,291 4.6 4.2

202005 412 2,309 4,523 2,175 676 384 10,067 178,269 5.6 5.0

202006 415 2,293 4,951 2,449 819 417 10,929 178,310 6.1 5.5

202007 411 2,028 4,166 2,311 749 405 9,659 169,367 5.7 5.2

202008 404 1,854 3,556 2,373 780 454 9,017 170,388 5.3 4.7

202009 400 1,636 3,062 2,048 785 522 8,053 165,774 4.9 4.5

202010 404 1,527 2,841 2,264 840 588 8,060 170,869 4.7 4.3

202011 388 1,489 2,725 2,625 878 556 8,273 150,878 5.5 4.6

202012 390 1,158 1,752 2,443 944 468 6,765 111,606 6.1 4.6

202013 369 468 673 1,542 617 314 3,614 81,752 4.4 3.1

202014 361 215 398 1,039 505 235 2,392 72,891 3.3 2.2

202015 370 128 315 844 439 215 1,941 78,327 2.5 1.8

202016 365 93 277 730 387 173 1,660 78,979 2.1 1.5

202017 361 103 282 747 372 172 1,676 88,132 1.9 1.5

202018 347 98 281 722 332 152 1,585 91,000 1.7 1.5

202019 291 74 254 629 276 135 1,368 80,659 1.7 1.2

Totals 154,518 4,636,167


HHS Region 6 (AR, LA, NM, OK, and TX) (Baseline: 3.8%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 309 1,117 1,254 660 217 134 3,382 122,699 2.8 2.2

201941 307 1,181 1,314 724 228 148 3,595 121,390 3.0 2.5

201942 311 1,193 1,478 850 260 143 3,924 121,617 3.2 2.6

201943 313 1,373 1,797 960 255 180 4,565 122,600 3.7 3.2

201944 315 1,610 2,119 1,125 332 201 5,387 120,455 4.5 3.7

201945 316 2,065 3,053 1,415 368 214 7,115 127,147 5.6 4.7

201946 306 2,300 3,333 1,671 396 230 7,930 125,373 6.3 5.0

201947 309 2,677 4,428 2,043 515 309 9,972 133,630 7.5 6.3

201948 309 2,509 2,970 1,907 518 290 8,194 108,631 7.5 6.8

201949 304 1,973 2,689 2,121 598 337 7,718 125,317 6.2 5.8

201950 283 1,947 3,093 1,811 488 311 7,650 112,757 6.8 7.7

201951 276 2,172 3,667 1,993 525 324 8,681 106,476 8.2 10.1

201952 273 2,942 4,069 2,985 827 551 11,374 104,199 10.9 13.4

202001 297 2,312 2,751 3,356 1,070 719 10,208 112,117 9.1 9.9

202002 308 1,834 2,891 3,198 1,079 549 9,551 121,644 7.9 8.8

202003 305 2,057 3,703 3,014 955 515 10,244 122,544 8.4 9.6

202004 308 2,217 4,223 3,016 974 491 10,921 124,949 8.7 9.8

202005 308 2,415 5,022 3,464 1,170 581 12,652 126,543 10.0 10.7

202006 307 2,259 4,553 3,212 1,084 497 11,605 117,214 9.9 10.3

202007 302 2,032 4,146 3,145 1,101 498 10,922 119,378 9.1 9.4

202008 303 1,958 3,701 3,008 1,070 563 10,300 120,208 8.6 8.7

202009 296 1,953 3,269 2,801 1,012 495 9,530 116,716 8.2 8.0

202010 293 1,690 3,084 2,924 1,036 597 9,331 118,771 7.9 7.8

202011 289 1,658 2,924 3,061 1,191 638 9,472 112,186 8.4 7.1

202012 277 1,277 2,213 3,439 1,387 734 9,050 91,922 9.8 8.3

202013 275 709 1,062 2,357 1,057 648 5,833 69,086 8.4 5.8

202014 266 334 577 1,427 727 482 3,547 57,247 6.2 4.2

202015 271 206 423 926 441 357 2,353 55,255 4.3 3.1

202016 267 157 336 674 317 228 1,712 52,892 3.2 2.3

202017 259 160 291 644 275 201 1,571 54,984 2.9 2.2

202018 249 127 239 488 228 181 1,263 57,228 2.2 1.7

202019 254 116 239 448 207 148 1,158 59,604 1.9 1.4

Totals 230,710 3,362,779


HHS Region 7 (IA, KS, MO, and NE) (Baseline: 1.7%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 130 109 166 72 25 16 388 36,003 1.1 .8

201941 132 129 189 73 32 26 449 35,517 1.3 .8

201942 130 174 237 93 26 23 553 37,930 1.5 1.0

201943 132 174 242 87 37 30 570 38,236 1.5 1.1

201944 132 176 212 83 40 32 543 35,531 1.5 1.2

201945 132 180 246 107 35 34 602 37,506 1.6 1.2

201946 132 257 261 109 47 30 704 36,610 1.9 1.7

201947 132 307 315 93 37 32 784 38,745 2.0 1.5

201948 130 402 261 130 65 51 909 29,265 3.1 1.7

201949 133 405 351 223 70 43 1,092 38,718 2.8 1.8

201950 133 452 502 273 85 53 1,365 37,677 3.6 2.2

201951 132 455 687 301 91 65 1,599 35,002 4.6 2.8

201952 129 677 870 525 153 102 2,327 28,680 8.1 5.6

202001 130 616 613 598 187 146 2,160 31,432 6.9 4.8

202002 129 457 566 528 186 114 1,851 33,939 5.5 3.6

202003 129 443 790 404 112 87 1,836 33,324 5.5 5.3

202004 129 412 848 411 125 62 1,858 34,151 5.4 6.1

202005 128 430 1,097 418 144 81 2,170 35,795 6.1 6.9

202006 129 456 1,231 471 127 107 2,392 36,735 6.5 7.3

202007 128 437 1,039 497 188 124 2,285 35,478 6.4 6.4

202008 129 449 942 481 182 113 2,167 36,125 6.0 5.9

202009 127 396 767 388 185 121 1,857 33,287 5.6 6.7

202010 126 411 798 395 149 133 1,886 34,946 5.4 7.0

202011 123 394 635 492 179 119 1,819 32,103 5.7 6.5

202012 120 328 368 531 194 95 1,516 24,793 6.1 5.9

202013 116 144 185 318 136 75 858 19,714 4.4 3.7

202014 116 48 102 216 98 69 533 17,271 3.1 2.0

202015 114 26 59 152 64 44 345 15,948 2.2 1.4

202016 111 31 44 108 36 29 248 15,733 1.6 1.1

202017 111 11 48 103 43 39 244 16,962 1.4 .9

202018 109 25 44 87 32 30 218 18,164 1.2 1.2

202019 101 8 28 76 33 26 171 18,088 .9 .6

Totals 38,299 989,408


HHS Region 8 (CO, MT, ND, SD, UT, and WY) (Baseline: 2.7%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 223 325 525 369 132 113 1,464 89,062 1.6 1.8

201941 229 332 511 380 162 120 1,505 94,226 1.6 1.8

201942 232 427 513 416 167 132 1,655 98,201 1.7 1.9

201943 231 402 554 430 166 164 1,716 96,380 1.8 2.0

201944 232 382 485 398 169 131 1,565 86,690 1.8 2.0

201945 227 511 603 392 146 122 1,774 93,003 1.9 2.1

201946 228 496 662 416 176 140 1,890 85,341 2.2 2.4

201947 228 603 775 465 170 149 2,162 89,171 2.4 2.6

201948 228 684 682 469 158 130 2,123 70,708 3.0 3.2

201949 230 676 790 567 210 159 2,402 86,046 2.8 3.0

201950 224 651 1,055 658 229 200 2,793 83,098 3.4 3.6

201951 223 893 1,368 793 248 232 3,534 86,211 4.1 4.4

201952 229 1,062 1,673 1,217 401 328 4,681 78,163 6.0 6.3

202001 227 1,054 1,200 1,176 434 367 4,231 77,108 5.5 5.8

202002 228 959 1,371 1,226 394 373 4,323 86,878 5.0 5.2

202003 223 1,030 1,711 1,161 389 342 4,633 86,732 5.3 5.6

202004 222 1,279 2,079 1,402 476 320 5,556 88,887 6.3 6.5

202005 224 1,318 2,429 1,463 529 363 6,102 92,522 6.6 6.8

202006 225 1,209 2,178 1,470 525 345 5,727 89,352 6.4 6.7

202007 221 1,058 1,740 1,179 477 355 4,809 86,262 5.6 5.9

202008 225 1,030 1,541 1,141 434 331 4,477 84,564 5.3 5.5

202009 224 909 1,432 1,163 480 323 4,307 89,104 4.8 5.0

202010 211 894 1,445 1,277 485 387 4,488 87,220 5.1 5.2

202011 215 852 1,645 1,647 645 377 5,166 84,775 6.1 6.3

202012 214 534 826 1,315 461 315 3,451 58,431 5.9 6.2

202013 206 237 371 726 273 190 1,797 47,850 3.8 4.0

202014 208 130 241 489 226 115 1,201 43,641 2.8 3.0

202015 205 72 181 338 152 84 827 40,602 2.0 2.1

202016 196 51 93 249 96 62 551 42,519 1.3 1.4

202017 196 47 112 218 86 66 529 44,367 1.2 1.2

202018 200 36 85 162 70 48 401 46,594 .9 .9

202019 177 39 89 122 69 43 362 43,198 .8 .8

Totals 92,202 2,456,906


HHS Region 9 (AZ, CA, HI, and NV) (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 194 250 434 183 107 98 1,072 82,804 1.3 1.3

201941 193 257 462 210 128 97 1,154 81,582 1.4 1.5

201942 198 281 536 205 137 114 1,273 80,939 1.6 1.6

201943 198 315 571 238 138 129 1,391 84,029 1.7 1.7

201944 199 371 595 265 133 116 1,480 82,038 1.8 1.8

201945 204 499 880 317 163 163 2,022 87,429 2.3 2.3

201946 206 566 1,095 411 179 160 2,411 90,206 2.7 2.6

201947 205 582 1,059 442 182 188 2,453 94,845 2.6 2.5

201948 203 517 762 412 175 165 2,031 67,021 3.0 2.9

201949 207 587 901 617 277 206 2,588 92,014 2.8 2.8

201950 205 566 970 503 236 225 2,500 89,704 2.8 2.8

201951 201 632 954 596 225 223 2,630 84,331 3.1 3.2

201952 204 723 892 670 273 258 2,816 65,035 4.3 4.6

202001 214 776 748 850 377 358 3,109 76,904 4.0 4.6

202002 214 641 1,151 872 442 401 3,507 101,190 3.5 3.8

202003 209 679 1,450 868 414 353 3,764 101,236 3.7 4.1

202004 212 828 1,761 923 432 397 4,341 100,529 4.3 4.7

202005 213 896 1,975 906 435 392 4,604 107,023 4.3 4.7

202006 208 971 1,884 992 451 397 4,695 106,680 4.4 4.9

202007 208 803 1,697 791 390 345 4,026 98,996 4.1 4.5

202008 210 778 1,346 867 471 432 3,894 97,894 4.0 4.4

202009 203 659 1,390 874 412 372 3,707 101,232 3.7 4.0

202010 185 650 1,203 740 314 300 3,207 95,168 3.4 3.7

202011 176 577 1,070 839 374 319 3,179 81,951 3.9 4.0

202012 165 357 551 693 287 234 2,122 50,228 4.2 4.6

202013 161 168 314 522 244 202 1,450 45,390 3.2 3.4

202014 151 103 197 346 186 189 1,021 39,326 2.6 2.7

202015 151 55 128 266 180 114 743 37,372 2.0 2.0

202016 154 44 119 178 119 122 582 39,632 1.5 1.5

202017 146 32 116 162 112 95 517 40,727 1.3 1.3

202018 137 30 98 150 111 101 490 42,531 1.2 1.2

202019 120 25 94 157 89 67 432 38,064 1.1 1.2

Totals 75,211 2,484,050


HHS Region 10 (AK, ID, OR, and WA) (Baseline: 1.5%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI

201940 166 94 227 223 95 99 738 71,045 1.0 1.0

201941 178 129 270 237 116 92 844 71,305 1.2 1.1

201942 178 160 275 265 105 87 892 72,289 1.2 1.2

201943 179 169 280 211 95 79 834 71,238 1.2 1.1

201944 181 185 273 207 85 83 833 68,251 1.2 1.2

201945 180 195 295 225 101 70 886 64,848 1.4 1.3

201946 179 192 304 212 83 83 874 64,886 1.3 1.4

201947 178 356 633 326 109 91 1,515 72,024 2.1 2.2

201948 183 316 554 286 104 94 1,354 56,732 2.4 2.8

201949 180 524 921 544 161 124 2,274 73,068 3.1 3.3

201950 180 634 1,374 729 219 166 3,122 74,636 4.2 4.5

201951 176 810 1,796 1,012 252 172 4,042 73,132 5.5 5.8

201952 169 1,139 2,127 1,233 331 285 5,115 71,965 7.1 7.2

202001 175 905 1,143 1,213 364 325 3,950 71,870 5.5 5.7

202002 179 562 869 940 345 264 2,980 73,781 4.0 4.1

202003 178 540 767 711 272 183 2,473 70,333 3.5 3.6

202004 177 622 889 770 283 180 2,744 72,732 3.8 3.8

202005 177 586 900 766 299 199 2,750 73,329 3.8 3.9

202006 178 568 803 654 283 155 2,463 72,597 3.4 3.5

202007 176 576 826 657 288 184 2,531 73,331 3.5 3.4

202008 174 650 806 667 278 200 2,601 73,118 3.6 3.6

202009 175 612 853 781 354 214 2,814 72,963 3.9 3.9

202010 178 645 1,149 1,186 501 344 3,825 72,812 5.3 5.6

202011 175 657 1,177 1,280 534 363 4,011 68,179 5.9 5.8

202012 170 538 779 1,238 518 339 3,412 54,189 6.3 5.9

202013 166 229 411 816 350 240 2,046 43,511 4.7 4.3

202014 165 117 219 486 270 148 1,240 39,053 3.2 3.1

202015 164 71 163 384 185 102 905 39,184 2.3 2.1

202016 164 59 129 232 106 81 607 39,396 1.5 1.8

202017 163 42 97 252 139 82 612 42,292 1.4 1.7

202018 158 78 142 197 79 72 568 55,895 1.0 1.2

202019 155 25 85 187 79 74 450 45,833 1.0 1.1

Totals 66,305 2,059,817


U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet):

Percentage of Visits for ILI by Age Group Reported by A Subset of ILINet Providers

September 29, 2019 - May 9, 2020


National

Week 0-4 years 5-24 years 25-49 years 50-64 years 65+ years

Total Visits

% ILI Total Visits

% ILI Total Visits

% ILI Total Visits

% ILI Total Visits

% ILI

201940 56,511 6.0 172,877 2.4 250,271 1.2 135,453 0.7 151,130 0.5

201941 58,900 6.2 171,817 2.4 248,234 1.3 137,075 0.8 155,136 0.6

201942 60,095 6.8 167,207 2.7 243,049 1.4 135,560 0.9 154,866 0.6

201943 61,228 7.1 176,476 2.9 250,335 1.5 139,567 0.9 158,388 0.6

201944 63,633 7.4 171,960 3.1 246,142 1.5 133,692 0.9 152,099 0.6

201945 66,353 8.4 174,266 3.7 243,709 1.7 133,263 1.0 152,172 0.6

201946 67,387 9.3 170,435 4.2 241,212 2.0 131,683 1.2 148,402 0.7

201947 73,442 9.7 177,411 5.0 253,835 2.2 139,061 1.3 154,298 0.8

201948 74,482 11.1 153,027 5.3 232,143 2.4 127,239 1.4 148,442 0.9

201949 73,402 10.6 175,342 4.9 255,947 2.8 137,089 1.6 156,155 1.0

201950 76,216 10.8 183,825 6.1 255,325 3.0 138,113 1.7 155,885 1.0

201951 81,520 12.4 183,593 8.3 252,285 3.7 135,369 1.9 155,745 1.2

201952 90,525 15.9 170,504 11.5 259,122 5.9 141,047 3.2 165,546 2.0

202001 86,829 14.7 162,965 8.3 279,963 5.9 149,120 3.5 169,822 2.4

202002 72,376 12.3 173,071 7.0 273,229 5.1 147,065 3.1 164,818 1.9

202003 73,404 12.7 183,417 8.1 266,032 4.8 143,273 2.9 159,818 1.7

202004 75,537 13.8 186,094 9.4 265,699 5.3 142,068 3.2 157,548 1.7

202005 78,816 14.6 208,539 10.5 277,528 6.3 144,784 3.9 160,096 2.0

202006 78,453 15.0 208,067 11.1 275,471 6.8 146,330 4.1 159,203 2.1

202007 75,501 13.5 196,708 9.7 273,952 6.1 148,062 3.8 162,546 2.0

202008 68,204 13.1 174,365 8.6 250,614 5.7 136,485 3.8 151,120 2.1

202009 67,915 11.8 179,907 7.4 261,277 5.4 142,026 3.6 157,868 2.0

202010 69,187 11.7 188,547 7.4 270,552 5.5 147,110 3.7 162,308 2.2

202011 66,162 12.5 184,915 8.5 273,844 6.8 143,218 4.9 149,445 2.7

202012 45,361 14.0 117,794 8.6 229,570 7.8 115,357 6.3 108,923 3.8

202013 29,107 10.4 83,139 5.7 193,714 6.4 98,986 5.9 94,259 3.8

202014 21,256 6.3 70,234 4.0 168,961 5.1 89,874 5.2 86,776 3.3

202015 19,336 4.2 66,757 2.9 156,464 3.7 87,667 3.9 88,279 2.6

202016 18,897 3.0 65,185 2.3 149,933 3.0 84,328 2.8 88,925 1.9

202017 20,013 2.5 70,868 1.8 160,386 2.3 90,930 2.1 96,578 1.4

202018 21,246 2.1 77,201 1.6 168,102 1.9 94,004 1.6 101,876 1.1

202019 21,538 1.7 80,414 1.4 172,953 1.5 98,091 1.3 105,331 0.9

Totals 1,912,832 4,926,927 7,599,853 4,112,989 4,533,803


National Syndromic Surveillance Program (NSSP): Emergency Department Visits

Percentage of Visits for COVID-19-Like Illness (CLI) or Influenza-like Illness (ILI)

September 29, 2019 - May 9, 2020


National

Week Number of Facilities

Reporting

Total Number of ED Visits

CLI Visits ILI Visits

Number Percent of Total Visits


201940 3,290 2,167,031 23,105 1.1 19,730 0.9

201941 3,283 2,121,815 24,056 1.1 20,603 1.0

201942 3,287 2,116,289 26,443 1.2 22,677 1.1

201943 3,284 2,137,265 27,531 1.3 23,928 1.1

201944 3,325 2,095,458 29,257 1.4 25,625 1.2

201945 3,336 2,143,883 33,907 1.6 30,134 1.4

201946 3,352 2,128,034 36,238 1.7 32,610 1.5

201947 3,364 2,215,902 39,280 1.8 36,245 1.6

201948 3,368 2,104,536 43,045 2.0 39,913 1.9

201949 3,370 2,231,578 41,801 1.9 37,849 1.7

201950 3,373 2,245,267 44,012 2.0 42,626 1.9

201951 3,374 2,228,800 49,648 2.2 51,027 2.3

201952 3,374 2,334,166 64,304 2.8 68,700 2.9

202001 3,382 2,410,847 58,739 2.4 57,663 2.4

202002 3,380 2,295,082 43,389 1.9 42,651 1.9

202003 3,390 2,265,908 42,372 1.9 44,676 2.0

202004 3,407 2,263,673 46,037 2.0 49,661 2.2

202005 3,421 2,356,110 54,052 2.3 59,802 2.5

202006 3,423 2,344,911 53,202 2.3 59,095 2.5

202007 3,437 2,278,873 47,421 2.1 50,970 2.2

202008 3,433 2,261,158 44,015 1.9 46,014 2.0

202009 3,444 2,224,885 40,802 1.8 41,831 1.9

202010 3,457 2,255,874 49,450 2.2 49,935 2.2

202011 3,453 2,241,661 76,763 3.4 71,520 3.2

202012 3,453 1,799,122 107,519 6.0 84,472 4.7

202013 3,459 1,445,316 99,309 6.9 62,351 4.3

202014 3,460 1,258,701 86,736 6.9 43,835 3.5

202015 3,447 1,197,096 72,311 6.0 30,151 2.5

202016 3,448 1,175,428 58,534 5.0 21,339 1.8

202017 3,437 1,244,781 52,380 4.2 17,466 1.4

202018 3,438 1,300,043 47,329 3.6 14,872 1.1

202019 3,439 1,354,470 38,214 2.8 12,514 0.9

Total 62,889,493 1,562,987 1,299,971




Reporting




Number Percent of Total

Visits

201940 203 132,270 1,032 0.8 749 0.6

201941 202 130,405 1,121 0.9 814 0.6

201942 202 132,409 1,208 0.9 912 0.7

201943 202 131,885 1,249 0.9 883 0.7

201944 203 128,273 1,203 0.9 888 0.7

201945 203 127,494 1,365 1.1 979 0.8

201946 202 125,328 1,538 1.2 1,188 0.9

201947 202 128,906 1,546 1.2 1,235 1.0

201948 202 124,803 1,794 1.4 1,451 1.2

201949 203 125,978 1,837 1.5 1,362 1.1

201950 202 130,466 1,788 1.4 1,405 1.1

201951 202 126,340 1,964 1.6 1,704 1.3

201952 203 136,115 2,733 2.0 2,483 1.8

202001 202 144,613 2,902 2.0 2,567 1.8

202002 202 140,140 2,349 1.7 2,191 1.6

202003 202 134,799 2,422 1.8 2,452 1.8

202004 201 139,764 2,732 2.0 2,945 2.1

202005 202 146,363 3,254 2.2 3,497 2.4

202006 202 143,968 3,222 2.2 3,612 2.5

202007 202 138,236 2,727 2.0 2,844 2.1

202008 202 132,292 2,306 1.7 2,291 1.7

202009 202 133,041 2,074 1.6 1,913 1.4

202010 199 129,462 2,377 1.8 2,297 1.8

202011 198 123,646 3,885 3.1 3,320 2.7

202012 199 91,546 5,449 6.0 3,607 3.9

202013 198 74,677 5,516 7.4 2,561 3.4

202014 198 66,794 6,087 9.1 2,091 3.1

202015 193 66,477 6,184 9.3 1,633 2.5

202016 192 65,849 5,899 9.0 1,340 2.0

202017 192 70,480 5,678 8.1 1,032 1.5

202018 192 73,497 4,784 6.5 729 1.0

202019 191 78,034 3,655 4.7 673 0.9

Total 3,696,316 90,225 58,975




Reporting





Visits

201940 196 225,733 2,136 0.9 1,782 0.8

201941 196 221,804 2,056 0.9 1,787 0.8

201942 195 219,993 2,322 1.1 2,002 0.9

201943 195 224,685 2,362 1.1 2,101 0.9

201944 196 220,716 2,708 1.2 2,342 1.1

201945 195 218,927 2,953 1.3 2,642 1.2

201946 196 215,927 3,260 1.5 2,798 1.3

201947 196 225,671 3,423 1.5 3,055 1.4

201948 196 216,693 3,924 1.8 3,626 1.7

201949 196 224,197 4,059 1.8 3,706 1.7

201950 196 230,456 4,329 1.9 4,122 1.8

201951 195 224,939 4,961 2.2 4,923 2.2

201952 195 239,681 6,489 2.7 6,864 2.9

202001 195 250,078 6,477 2.6 6,739 2.7

202002 195 243,396 4,980 2.0 5,342 2.2

202003 195 238,507 5,057 2.1 5,617 2.4

202004 195 238,640 5,614 2.4 6,432 2.7

202005 195 245,378 6,123 2.5 7,050 2.9

202006 195 241,579 5,816 2.4 6,702 2.8

202007 195 228,900 4,643 2.0 5,202 2.3

202008 195 222,235 3,958 1.8 4,219 1.9

202009 195 222,044 3,568 1.6 3,696 1.7

202010 195 222,253 4,796 2.2 5,000 2.2

202011 195 223,506 9,794 4.4 9,203 4.1

202012 195 188,426 17,808 9.5 14,306 7.6

202013 195 166,916 23,370 14.0 15,270 9.1

202014 194 144,625 23,033 15.9 11,751 8.1

202015 195 123,499 17,884 14.5 7,083 5.7

202016 195 110,024 12,295 11.2 4,053 3.7

202017 194 106,980 8,363 7.8 2,285 2.1

202018 194 109,942 6,264 5.7 1,569 1.4

202019 194 114,178 4,322 3.8 1,077 0.9

Total 6,436,350 214,825 163,269




Reporting





Visits

201940 331 233,555 2,038 0.9 1,590 0.7

201941 332 231,137 2,118 0.9 1,619 0.7

201942 332 226,253 2,249 1.0 1,706 0.8

201943 333 231,358 2,294 1.0 1,741 0.8

201944 334 229,668 2,379 1.0 1,814 0.8

201945 333 224,882 2,574 1.1 2,000 0.9

201946 336 225,109 2,830 1.3 2,266 1.0

201947 339 233,832 3,123 1.3 2,451 1.0

201948 340 221,028 3,409 1.5 2,768 1.3

201949 337 233,888 3,361 1.4 2,787 1.2

201950 335 237,353 3,624 1.5 3,138 1.3

201951 339 236,500 4,065 1.7 3,726 1.6

201952 337 250,325 5,397 2.2 5,285 2.1

202001 339 264,016 5,288 2.0 4,652 1.8

202002 337 248,332 3,821 1.5 3,283 1.3

202003 340 243,112 3,591 1.5 3,389 1.4

202004 344 243,715 3,834 1.6 3,848 1.6

202005 345 253,577 4,523 1.8 4,677 1.8

202006 342 253,547 4,398 1.7 4,754 1.9

202007 344 247,466 4,131 1.7 4,053 1.6

202008 345 243,179 3,576 1.5 3,422 1.4

202009 344 241,067 3,538 1.5 3,440 1.4

202010 354 248,270 4,283 1.7 3,971 1.6

202011 353 246,993 6,903 2.8 6,120 2.5

202012 353 190,933 10,078 5.3 7,349 3.8

202013 353 151,642 8,294 5.5 4,850 3.2

202014 354 132,832 7,642 5.8 3,507 2.6

202015 355 128,206 7,596 5.9 2,805 2.2

202016 353 128,412 7,391 5.8 2,238 1.7

202017 354 136,344 7,492 5.5 2,047 1.5

202018 356 144,675 7,314 5.1 1,807 1.2

202019 353 149,174 5,993 4.0 1,552 1.0

Total 6,761,206 143,154 103,103




Reporting





Visits

201940 813 612,147 8,565 1.4 7,573 1.2

201941 816 595,603 8,665 1.5 7,871 1.3

201942 818 592,924 9,282 1.6 8,209 1.4

201943 817 602,575 9,904 1.6 8,859 1.5

201944 841 599,203 10,754 1.8 9,892 1.7

201945 841 606,224 12,472 2.1 11,438 1.9

201946 857 595,808 13,191 2.2 12,172 2.0

201947 863 620,092 14,197 2.3 13,276 2.1

201948 864 600,100 15,303 2.6 14,573 2.4

201949 868 634,344 13,935 2.2 12,883 2.0

201950 871 638,312 14,565 2.3 14,743 2.3

201951 870 640,064 16,970 2.7 18,121 2.8

201952 869 659,500 20,694 3.1 22,518 3.4

202001 868 676,420 17,723 2.6 16,740 2.5

202002 868 641,316 12,796 2.0 12,187 1.9

202003 871 649,133 13,115 2.0 13,368 2.1

202004 875 625,306 13,648 2.2 13,693 2.2

202005 879 659,837 16,437 2.5 17,012 2.6

202006 880 673,848 17,036 2.5 17,638 2.6

202007 881 656,462 14,677 2.2 14,804 2.3

202008 881 640,286 13,382 2.1 12,841 2.0

202009 882 624,212 12,455 2.0 11,773 1.9

202010 885 640,325 15,762 2.5 14,998 2.3

202011 885 645,700 22,966 3.6 20,972 3.2

202012 884 527,470 29,249 5.5 23,364 4.4

202013 885 418,511 23,782 5.7 15,681 3.7

202014 888 351,868 17,615 5.0 9,970 2.8

202015 888 332,739 13,592 4.1 6,887 2.1

202016 885 331,306 10,855 3.3 5,090 1.5

202017 884 347,736 9,368 2.7 4,159 1.2

202018 886 357,102 8,411 2.4 3,653 1.0

202019 884 379,133 6,974 1.8 3,157 0.8

Total 17,796,473 451,366 396,958




Reporting





Visits

201940 693 405,293 3,896 1.0 3,279 0.8

201941 688 394,809 4,240 1.1 3,492 0.9

201942 687 389,594 4,666 1.2 3,871 1.0

201943 688 395,285 4,810 1.2 4,048 1.0

201944 693 381,931 4,819 1.3 3,968 1.0

201945 699 388,182 5,266 1.4 4,277 1.1

201946 697 381,764 5,258 1.4 4,420 1.2

201947 698 402,317 5,831 1.4 4,941 1.2

201948 698 382,055 6,710 1.8 5,820 1.5

201949 699 414,200 7,281 1.8 6,379 1.5

201950 699 411,940 8,158 2.0 7,580 1.8

201951 700 411,812 8,879 2.2 9,041 2.2

201952 699 438,972 12,120 2.8 13,177 3.0

202001 700 450,620 11,192 2.5 11,402 2.5

202002 698 420,156 7,691 1.8 7,930 1.9

202003 701 401,883 7,129 1.8 8,034 2.0

202004 708 413,456 7,912 1.9 9,332 2.3

202005 709 434,494 9,703 2.2 12,309 2.8

202006 709 430,855 9,220 2.1 12,038 2.8

202007 709 411,968 8,152 2.0 10,316 2.5

202008 708 417,938 7,720 1.8 9,733 2.3

202009 711 409,758 7,146 1.7 8,773 2.1

202010 709 416,559 7,615 1.8 9,091 2.2

202011 707 414,838 12,008 2.9 12,558 3.0

202012 709 325,822 17,976 5.5 14,595 4.5

202013 709 257,810 16,485 6.4 9,735 3.8

202014 708 228,019 14,955 6.6 7,028 3.1

202015 705 214,789 12,766 5.9 4,839 2.3

202016 706 210,696 11,142 5.3 3,877 1.8

202017 710 228,067 11,074 4.9 3,592 1.6

202018 709 241,600 10,909 4.5 3,258 1.3

202019 713 248,630 9,142 3.7 2,632 1.1

Total 11,527,482 272,729 232,733




Reporting





Visits

201940 348 204,707 2,141 1.0 1,896 0.9

201941 347 195,896 2,210 1.1 1,941 1.0

201942 345 197,688 2,579 1.3 2,275 1.2

201943 348 194,884 2,646 1.4 2,459 1.3

201944 348 189,643 2,977 1.6 2,825 1.5

201945 348 207,944 3,910 1.9 3,753 1.8

201946 349 206,048 4,267 2.1 4,106 2.0

201947 352 222,884 5,004 2.2 5,057 2.3

201948 349 207,003 5,158 2.5 4,984 2.4

201949 348 212,946 4,369 2.1 4,062 1.9

201950 351 209,942 4,045 1.9 4,039 1.9

201951 346 205,494 4,425 2.2 4,733 2.3

201952 350 219,006 5,834 2.7 6,434 2.9

202001 348 218,572 4,754 2.2 4,845 2.2

202002 350 204,385 3,557 1.7 3,547 1.7

202003 353 207,593 3,409 1.6 3,630 1.7

202004 352 202,915 3,691 1.8 4,194 2.1

202005 355 207,966 4,191 2.0 4,659 2.2

202006 359 202,318 4,111 2.0 4,456 2.2

202007 364 197,486 3,776 1.9 3,980 2.0

202008 366 199,051 3,706 1.9 3,825 1.9

202009 369 193,210 3,376 1.7 3,372 1.7

202010 370 200,879 4,006 2.0 3,985 2.0

202011 371 203,702 6,223 3.1 5,733 2.8

202012 371 166,732 8,588 5.2 6,747 4.0

202013 372 125,872 7,313 5.8 4,752 3.8

202014 372 113,031 5,781 5.1 3,068 2.7

202015 371 117,051 5,237 4.5 2,445 2.1

202016 372 115,216 3,851 3.3 1,595 1.4

202017 360 123,577 3,472 2.8 1,420 1.1

202018 358 128,187 3,234 2.5 1,315 1.0

202019 353 134,418 2,792 2.1 1,139 0.8

Total 5,801,828 131,841 116,132




Reporting





Visits

201940 229 84,502 933 1.1 973 1.2

201941 228 80,958 1,036 1.3 1,066 1.3

201942 228 84,350 1,311 1.6 1,378 1.6

201943 226 83,373 1,381 1.7 1,387 1.7

201944 228 78,909 1,329 1.7 1,331 1.7

201945 227 83,323 1,492 1.8 1,520 1.8

201946 225 80,968 1,581 2.0 1,535 1.9

201947 226 86,517 1,819 2.1 1,853 2.1

201948 229 81,862 2,027 2.5 2,063 2.5

201949 229 87,860 2,000 2.3 1,988 2.3

201950 227 86,985 2,239 2.6 2,308 2.7

201951 231 83,703 2,567 3.1 2,691 3.2

201952 231 91,590 3,197 3.5 3,416 3.7

202001 239 92,065 2,809 3.1 2,874 3.1

202002 234 84,544 2,011 2.4 2,025 2.4

202003 236 82,880 1,891 2.3 2,056 2.5

202004 241 82,403 1,837 2.2 2,080 2.5

202005 244 87,660 2,222 2.5 2,558 2.9

202006 242 87,874 2,354 2.7 2,725 3.1

202007 244 87,137 2,516 2.9 2,884 3.3

202008 244 90,002 2,499 2.8 2,791 3.1

202009 247 88,937 2,247 2.5 2,563 2.9

202010 249 88,421 2,233 2.5 2,423 2.7

202011 249 85,713 2,813 3.3 2,849 3.3

202012 251 70,638 3,462 4.9 3,143 4.4

202013 253 58,036 2,608 4.5 2,071 3.6

202014 253 51,016 1,839 3.6 1,293 2.5

202015 251 49,648 1,398 2.8 882 1.8

202016 251 47,370 1,133 2.4 652 1.4

202017 251 51,521 1,097 2.1 620 1.2

202018 251 55,523 1,116 2.0 502 0.9

202019 252 56,451 877 1.6 439 0.8

Total 2,436,288 60,997 60,500



Week

Number of Facilities

Reporting Total Number of

ED Visits


Number Percent of Total Visits Number

Percent of Total Visits

201940 151 47,371 367 0.8 285 0.6

201941 152 47,028 431 0.9 303 0.6

201942 152 47,905 436 0.9 333 0.7

201943 150 46,884 385 0.8 340 0.7

201944 155 46,003 427 0.9 316 0.7

201945 158 53,760 592 1.1 477 0.9

201946 157 54,370 606 1.1 484 0.9

201947 154 55,429 698 1.3 630 1.1

201948 157 52,872 844 1.6 751 1.4

201949 158 56,507 731 1.3 633 1.1

201950 161 56,036 814 1.5 765 1.4

201951 160 56,694 912 1.6 919 1.6

201952 157 59,663 1,433 2.4 1,513 2.5

202001 159 63,203 1,263 2.0 1,354 2.1

202002 160 60,874 1,193 2.0 1,165 1.9

202003 159 60,102 1,096 1.8 1,180 2.0

202004 160 62,386 1,334 2.1 1,415 2.3

202005 160 63,951 1,554 2.4 1,680 2.6

202006 164 61,598 1,394 2.3 1,461 2.4

202007 164 61,155 1,276 2.1 1,396 2.3

202008 161 61,816 1,341 2.2 1,455 2.4

202009 162 61,201 1,283 2.1 1,332 2.2

202010 163 61,943 1,435 2.3 1,516 2.4

202011 162 61,581 2,507 4.1 2,295 3.7

202012 160 50,000 3,109 6.2 2,368 4.7

202013 161 42,213 2,794 6.6 1,643 3.9

202014 162 37,662 2,427 6.4 1,220 3.2

202015 160 36,821 1,946 5.3 857 2.3

202016 162 35,428 1,562 4.4 599 1.7

202017 161 39,497 1,574 4.0 536 1.4

202018 161 41,565 1,468 3.5 434 1.0

202019 165 41,715 1,256 3.0 419 1.0

Total 1,643,518 39,232 31,655




Reporting





Visits

201940 135 130,062 1,273 1.0 1,113 0.9

201941 135 132,244 1,464 1.1 1,211 0.9

201942 136 132,256 1,589 1.2 1,375 1.0

201943 137 134,297 1,708 1.3 1,535 1.1

201944 137 133,211 1,888 1.4 1,653 1.2

201945 141 143,849 2,356 1.6 2,304 1.6

201946 142 147,614 2,584 1.8 2,685 1.8

201947 140 144,927 2,514 1.7 2,688 1.9

201948 140 126,370 2,501 2.0 2,527 2.0

201949 139 143,634 2,776 1.9 2,697 1.9

201950 139 145,184 2,720 1.9 2,724 1.9

201951 138 143,682 2,920 2.0 2,929 2.0

201952 140 135,996 3,798 2.8 4,018 3.0

202001 138 147,149 4,021 2.7 4,028 2.7

202002 140 153,878 3,365 2.2 3,411 2.2

202003 140 155,272 3,294 2.1 3,667 2.4

202004 139 157,380 3,996 2.5 4,290 2.7

202005 139 159,946 4,351 2.7 4,646 2.9

202006 138 154,347 4,022 2.6 4,209 2.7

202007 138 153,378 3,956 2.6 4,009 2.6

202008 138 156,557 3,822 2.4 3,885 2.5

202009 139 153,326 3,225 2.1 3,259 2.1

202010 139 150,394 3,738 2.5 3,659 2.4

202011 140 143,239 5,050 3.5 4,575 3.2

202012 138 110,524 6,455 5.8 5,097 4.6

202013 138 86,775 5,055 5.8 3,371 3.9

202014 138 76,587 4,225 5.5 2,498 3.3

202015 137 71,080 3,321 4.7 1,719 2.4

202016 139 73,605 2,663 3.6 1,257 1.7

202017 139 79,360 2,672 3.4 1,153 1.5

202018 139 83,268 2,463 3.0 1,048 1.3

202019 140 85,859 2,130 2.5 984 1.1

Total 4,059,391 99,785 89,240




Reporting





Visits

201940 191 91,391 724 0.8 490 0.5

201941 187 91,931 715 0.8 499 0.5

201942 192 92,917 801 0.9 616 0.7

201943 188 92,039 792 0.9 575 0.6

201944 190 87,901 773 0.9 596 0.7

201945 191 89,298 927 1.0 744 0.8

201946 191 95,098 1,123 1.2 956 1.0

201947 194 95,327 1,125 1.2 1,059 1.1

201948 193 91,750 1,375 1.5 1,350 1.5

201949 193 98,024 1,452 1.5 1,352 1.4

201950 192 98,593 1,730 1.8 1,802 1.8

201951 193 99,572 1,985 2.0 2,240 2.2

201952 193 103,318 2,609 2.5 2,992 2.9

202001 194 104,111 2,310 2.2 2,462 2.4

202002 196 98,061 1,626 1.7 1,570 1.6

202003 193 92,627 1,368 1.5 1,283 1.4

202004 192 97,708 1,439 1.5 1,432 1.5

202005 193 96,938 1,694 1.7 1,714 1.8

202006 192 94,977 1,629 1.7 1,500 1.6

202007 196 96,685 1,567 1.6 1,482 1.5

202008 193 97,802 1,705 1.7 1,552 1.6

202009 193 98,089 1,890 1.9 1,710 1.7

202010 194 97,368 3,205 3.3 2,995 3.1

202011 193 92,743 4,614 5.0 3,895 4.2

202012 193 77,031 5,345 6.9 3,896 5.1

202013 195 62,864 4,092 6.5 2,417 3.8

202014 193 56,267 3,132 5.6 1,409 2.5

202015 192 56,786 2,387 4.2 1,001 1.8

202016 193 57,522 1,743 3.0 638 1.1

202017 192 61,219 1,590 2.6 622 1.0

202018 192 64,684 1,366 2.1 557 0.9

202019 194 66,878 1,073 1.6 442 0.7

Total 2,730,641 58,833 47,406


NCHS Mortality Surveillance Data


For the Week Ending May 9, 2020 (Week 19)

Year Week Total Deaths Pneumonia, Influenza or

COVID-19 Deaths Baseline Threshold

Number % of Total

2019 40 52,482 2,726 5.2 5.3 5.7

2019 41 52,898 2,788 5.3 5.4 5.7

2019 42 54,169 3,001 5.5 5.5 5.8

2019 43 53,944 3,021 5.6 5.6 5.9

2019 44 54,018 2,946 5.5 5.7 6.0

2019 45 55,530 3,097 5.6 5.8 6.2

2019 46 55,760 3,137 5.6 5.9 6.3

2019 47 56,067 3,052 5.4 6.0 6.4

2019 48 55,303 3,052 5.5 6.2 6.5

2019 49 57,096 3,413 6.0 6.3 6.6

2019 50 57,425 3,574 6.2 6.4 6.7

2019 51 57,168 3,487 6.1 6.5 6.8

2019 52 58,201 3,711 6.4 6.6 6.9

2020 1 59,576 4,469 7.5 6.7 7.0

2020 2 59,919 4,541 7.6 6.7 7.1

2020 3 58,400 4,429 7.6 6.8 7.2

2020 4 57,855 4,298 7.4 6.9 7.2

2020 5 57,526 4,177 7.3 6.9 7.3

2020 6 58,128 4,209 7.2 7.0 7.3

2020 7 57,468 4,265 7.4 7.0 7.3

2020 8 57,495 4,155 7.2 7.0 7.3

2020 9 57,769 4,340 7.5 7.0 7.3

2020 10 57,350 4,416 7.7 7.0 7.3

2020 11 55,812 4,398 7.9 6.9 7.3

2020 12 55,916 5,073 9.1 6.9 7.2

2020 13 58,988 7,710 13.1 6.8 7.1

2020 14 66,754 13,897 20.8 6.7 7.1

2020 15 72,070 18,728 26.0 6.7 7.0

2020 16 67,279 17,573 26.1 6.6 6.9

2020 17 57,948 13,362 23.1 6.5 6.8

2020 18 43,586 7,748 17.8 6.4 6.7

2020 19 22,044 2,832 12.8 6.3 6.6

Documents

Outpatient and Emergency Department Visits€¦ · 15-05-2020 · • Public health laboratories – decreased from 13.1% during week 18 to 11.8% during week 19; • Clinical laboratories